| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec0024795f45a646ef64b3664ab8a26d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_feb791cea0d8bad45415346d3a0f3de7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0402 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-06 |
| filingDate |
2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27b68b805ef1ce550e6dd05ce595589a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7985925c4a5a2cefea2f7ee46dc5190
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cfbe3b846e1f527d492ebb1eb2fa2f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c7c0abeaea8a4876e11edac993fff09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aeaccc9f7c0363b170f3ad38047cac1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8eb5eca5ab516babf7f0ba2b92327baa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6625834b2390e52546ee2e4e331b434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b07ca0252b5579db73fbacbe6644158 |
| publicationDate |
2017-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3209336-A1 |
| titleOfInvention |
18f-tagged inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| abstract |
The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of prostate cancer. |
| priorityDate |
2014-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |